Thursday, July 7, 2016
Growing Number of GI and Gynecological Surgeries to have Positive Implications on Global Anti-Adhesion Products Market
Transparency Market Research’s new report within the medical devices industry sheds light on the growth pattern of the anti-adhesion products market. The report, titled “Anti-Adhesion Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” discusses how the growing number of surgeries performed is creating new economic opportunities in the market.
About 50% to 90% of patients that undergo surgery are victims to post-surgical adhesion. This is a serious problem where the wrong tissues connect with each other after a surgery. Some of the more common problems caused by post-surgical adhesion include intestinal blockage, pelvic pain, numbness, and infertility. These complications will vary according to the location of the surgery, the type of adhesion, and the magnitude of the adhesion.
Brochure Download for Detailed Analysis: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1506
Anti-adhesion products can be envisioned as barriers between the healing tissues and the surrounding healthy tissues. Most anti-adhesion films, fabrics, or gels, are designed to dissolve after a certain period of time, removing the necessity of further medical intervention. These products are usually dissolved into bodily fluids and are excreted naturally.
The global anti-adhesion products market identifies these adhesions based on their location, into pelvic, intraperitoneal, and abdominal adhesions. The market size is therefore directly proportional to the surgical procedures that are most likely to cause adhesion. These include most types of plastic surgeries, gynecological surgeries, thoracic surgeries, and abdominal surgeries. Therefore, the global anti-adhesion products market is currently driven by the increasing number of the above surgical procedures.
Of the major geographical regions of the global anti-adhesion products market, North America, has visibly dominated it for quite a few years. One of the primary reasons for this region’s dominance is the high rate of approval of anti-adhesive products by the U.S. FDA. At the same time, this region is showing a high demand for gynecological and gastrointestinal surgeries. Similar cases can be made regarding the rapid growth of the anti-adhesion products market in the Asia Pacific region. This is especially true in the case of the burgeoning medical tourism market in the Asia Pacific, which is another driver for the global anti-adhesion products market.
The future of the global anti-adhesion products market is expected to hold the release of products that are increasingly efficient and cost-effective. This will further ramp up the growth rate of the global anti-adhesion products market.
Key players in the global anti-adhesion products market include MAST Biosurgery AG., LifeCell Corporation, Genzyme Corporation, Angiotech Pharmaceuticals, Inc., Anika Therapeutics, Inc., WL Gore, Baxter International, and Johnson & Johnson.
Some of the more commonly used anti-adhesion products around the world include Seprafilm, Interseed, and Surgiwrap.